Clinical Trial Update: Hepatic Arterial Infusion Chemotherapy With Fruquintinib for Colorectal Cancer Liver Metastases As Third-line Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating hepatic arterial infusion chemotherapy with Fruquintinib as third-line therapy for colorectal cancer with liver metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Drugs mentioned

• Fruquintinib (fruquintinib)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Advanced Colorectal Carcinoma, Liver Metastasis Colon Cancer | Phase 2 | Status: UNKNOWN